{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:09:56Z","timestamp":1777136996555,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004343","name":"3M Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007231","name":"Cornell University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007231","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.yexmp.2025.104990","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T04:10:29Z","timestamp":1753848629000},"page":"104990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Twenty-eight-day perfluorooctanoate exposure does not affect immune cell populations in na\u00efve mice"],"prefix":"10.1016","volume":"143","author":[{"given":"Candice","family":"Limper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Silliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Ciocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Imbiakha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie","family":"Redko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen M.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Sahler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avery","family":"August","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yexmp.2025.104990_bb0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/toxsci\/kfm110","article-title":"Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha","volume":"98","author":"Abbott","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yexmp.2025.104990_bb0010","series-title":"Toxicological Profile for Perfluoroalkyls","author":"Agency for Toxic Substances and Disease Registry","year":"2021"},{"key":"10.1016\/j.yexmp.2025.104990_bb0015","author":"Agency for Toxic Substances and Disease Registry"},{"issue":"8","key":"10.1016\/j.yexmp.2025.104990_bb0020","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00204-022-03303-4","article-title":"Immunomodulation and exposure to per- and polyfluoroalkyl substances: an overview of the current evidence from animal and human studies","volume":"96","author":"Antoniou","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"307","key":"10.1016\/j.yexmp.2025.104990_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab2271","article-title":"Early infancy microbial and metabolic alterations affect risk of childhood asthma","volume":"7","author":"Arrieta","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.yexmp.2025.104990_bb0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1289\/ehp.0901252","article-title":"Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia","volume":"118","author":"Bartell","year":"2010","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.yexmp.2025.104990_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/toxsci\/60.1.44","article-title":"Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats","volume":"60","author":"Biegel","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yexmp.2025.104990_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105502","article-title":"Range of the perfluorooctanoate (PFOA) safe dose for human health: an international collaboration","volume":"145","author":"Burgoon","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.yexmp.2025.104990_bb0045","first-page":"1","article-title":"Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley rats","volume":"298","author":"Butenhoff","year":"2012","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.yexmp.2025.104990_bb0050","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.reprotox.2011.08.004","article-title":"Toxicological evaluation of ammonium perfluorobutyrate in rats: twenty-eight-day and ninety-day oral gavage studies","volume":"33","author":"Butenhoff","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yexmp.2025.104990_bb0055","author":"Center for Disease Control and Prevention (US)"},{"key":"10.1016\/j.yexmp.2025.104990_bb0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.toxlet.2021.09.002","article-title":"Suppression of Th2 cytokines as a potential mechanism for reduced antibody response following PFOA exposure in female B6C3F1 mice","volume":"351","author":"De Guise","year":"2021","journal-title":"Toxicol. Lett."},{"issue":"5","key":"10.1016\/j.yexmp.2025.104990_bb0065","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1289\/ehp.10896","article-title":"Perfluorooctanoic acid-induced immunomodulation in adult C57BL\/6J or C57BL\/6N female mice","volume":"116","author":"Dewitt","year":"2008","journal-title":"Environ. Health Perspect."},{"issue":"4","key":"10.1016\/j.yexmp.2025.104990_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1289\/ehp.1205351","article-title":"Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children","volume":"121","author":"Dong","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yexmp.2025.104990_bb0075","series-title":"PFAS National Primary Drinking Water Regulation; Correction","author":"EPA","year":"2024"},{"issue":"2","key":"10.1016\/j.yexmp.2025.104990_bb0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/toxsci\/kfm053","article-title":"Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin","volume":"97","author":"Fairley","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"12","key":"10.1016\/j.yexmp.2025.104990_bb0085","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1289\/ehp.0800379","article-title":"The C8 health project: design, methods, and participants","volume":"117","author":"Frisbee","year":"2009","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.yexmp.2025.104990_bb0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/10408444.2023.2194913","article-title":"Weight of evidence evaluation for chemical-induced immunotoxicity for PFOA and PFOS: findings from an independent panel of experts","volume":"53","author":"Garvey","year":"2023","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.yexmp.2025.104990_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/tx200363w","article-title":"Renal elimination of perfluorocarboxylates (PFCAs)","volume":"25","author":"Han","year":"2012","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.yexmp.2025.104990_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.taap.2003.11.031","article-title":"The developmental toxicity of perfluoroalkyl acids and their derivatives","volume":"198","author":"Lau","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.yexmp.2025.104990_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.04.056","article-title":"Half-life of IgE in serum and skin: consequences for anti-IgE therapy in patients with allergic disease","volume":"139","author":"Lawrence","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.yexmp.2025.104990_bb0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/toxsci\/kfn234","article-title":"Modeling single and repeated dose pharmacokinetics of PFOA in mice","volume":"107","author":"Lou","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.yexmp.2025.104990_bb0115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-3083.1989.tb01221.x","article-title":"Regulation of IgG1 and IgE synthesis by interleukin 4 in mouse B cells","volume":"30","author":"Moon","year":"1989","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.yexmp.2025.104990_bb0120","author":"National Toxicology Program"},{"key":"10.1016\/j.yexmp.2025.104990_bb0125","unstructured":"National Toxicology Program. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Perfluorooctanoic Acid (CASRN 335-67-1) Administered in Feed to Sprague Dawley (Hsd:Sprague Dawley\u00ae SD\u00ae) Rats (Revised): Technical Report 598. National Toxicology Program. 2023. [Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560147\/] 10.22427\/NTP-TR-598."},{"issue":"3","key":"10.1016\/j.yexmp.2025.104990_bb0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1067\/mai.2001.113759","article-title":"IgE regulation and roles in asthma pathogenesis","volume":"107","author":"Oettgen","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.yexmp.2025.104990_bb0135","series-title":"PFAS Biomonitoring in Higher Exposed Populations. Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances","first-page":"77","author":"Olsen","year":"2015"},{"key":"10.1016\/j.yexmp.2025.104990_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.envres.2017.05.013","article-title":"Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000-2015","volume":"157","author":"Olsen","year":"2017","journal-title":"Environ. Res."},{"issue":"1","key":"10.1016\/j.yexmp.2025.104990_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pharmthera.2006.07.003","article-title":"Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic","volume":"113","author":"Owen","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexmp.2025.104990_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1228509","article-title":"C57BL\/6J mice exposed to perfluorooctanoic acid demonstrate altered immune responses and increased seizures after Theiler\u2019s murine encephalomyelitis virus infection","volume":"14","author":"P\u00e9rez G\u00f3mez","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2025.104990_bb0155","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.envint.2013.06.004","article-title":"Accumulation of perfluoroalkyl substances in human tissues","volume":"59","author":"P\u00e9rez","year":"2013","journal-title":"Environ. Int."},{"issue":"4","key":"10.1016\/j.yexmp.2025.104990_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1081\/DCT-200039773","article-title":"13-week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats","volume":"27","author":"Perkins","year":"2004","journal-title":"Drug Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.yexmp.2025.104990_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152356","article-title":"Effects of PFOS and cyclophosphamide exposure on immune homeostasis in mice","volume":"228","author":"Pierpont","year":"2023","journal-title":"Immunobiology"},{"issue":"8","key":"10.1016\/j.yexmp.2025.104990_bb0170","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/immunohorizons.2300049","article-title":"Effects of perfluorohexane sulfonate exposure on immune cell populations in naive mice","volume":"8","author":"Pierpont","year":"2024","journal-title":"Immunohorizons"},{"key":"10.1016\/j.yexmp.2025.104990_bb0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.chemosphere.2014.07.061","article-title":"Calculation of chemical elimination half-life from blood with an ongoing exposure source: the example of perfluorooctanoic acid (PFOA)","volume":"129","author":"Russell","year":"2015","journal-title":"Chemosphere"},{"issue":"9","key":"10.1016\/j.yexmp.2025.104990_bb0180","article-title":"Risk to human health related to the presence of perfluoroalkyl substances in food","volume":"18","author":"Schrenk","year":"2020","journal-title":"EFSA J."},{"issue":"8","key":"10.1016\/j.yexmp.2025.104990_bb0185","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1289\/ehp.1206449","article-title":"Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley","volume":"121","author":"Steenland","year":"2013","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.yexmp.2025.104990_bb0190","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/pr.2015.213","article-title":"Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12\u201319 y: National Health and Nutrition Examination Survey","volume":"79","author":"Stein","year":"2016","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.yexmp.2025.104990_bb0195","first-page":"165","article-title":"Occurrence and toxicology aspects of perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) in the environment and food: a review","volume":"17","author":"Tahziz","year":"2021","journal-title":"Malays. J. Med. Health Sci."},{"issue":"1","key":"10.1016\/j.yexmp.2025.104990_bb0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/toxsci\/kfad043","article-title":"Quantifying the impact of PFOA exposure on B-cell development and antibody production","volume":"194","author":"Taylor","year":"2023","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yexmp.2025.104990_bb0205","author":"United States Environmental Protection Agency"},{"key":"10.1016\/j.yexmp.2025.104990_bb0210","author":"United States Environmental Protection Agency"},{"issue":"2","key":"10.1016\/j.yexmp.2025.104990_bb0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/eji.1830180221","article-title":"The half-lives of serum immunoglobulins in adult mice","volume":"18","author":"Vieira","year":"1988","journal-title":"Eur. J. Immunol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:20:41Z","timestamp":1769044841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480025000401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"alternative-id":["S0014480025000401"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.104990","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twenty-eight-day perfluorooctanoate exposure does not affect immune cell populations in na\u00efve mice","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.104990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104990"}}